18 results on '"E. Baamonde"'
Search Results
2. DIALYSIS. PATHOPHYSIOLOGY AND CLINICAL STUDIES
- Author
-
J. K. Humalda, S. Assa, G. J. Navis, C. F. M. Franssen, M. H. De Borst, H. Ogawa, Y. Ota, T. Watanabe, Y. Watanabe, H. Nishii, A. Sato, J. Waniewski, M. Debowska, A. Wojcik-Zaluska, A. Ksiazek, W. Zaluska, C. M. Guastoni, C. Turri, L. Toma, G. Rombola, G. Frattini, G. Romei Longhena, U. Teatini, D.-C. Siriopol, S. Stuard, A. Ciolan, G. Mircescu, D. Raluca, I. Nistor, A. Covic, C. L. De Roij Van Zuijdewijn, I. Chapdelaine, M. J. Nube, P. J. Blankestijn, M. L. Bots, S. J. Konings, M. A. Van Den Dorpel, N. C. Van Der Weerd, P. M. Ter Wee, M. P. Grooteman, P. S. Djuric, A. Jankovic, J. Tosic, S. Bajcetic, T. Damjanovic, J. Popovic, N. Dimkovic, J. Marinkovic, Z. Djuric, V. Knezevic, T. Lazarevic, S. Ljubenovic, R. Markovic, V. Rabrenovic, L. Djukanovic, V. Radovic Maslarevic, V. Mathrani, P. Drew, J. I. Chess, A. I. Williams, S. Robertson, M. Jibani, V. I. Aithal, M. Kumwenda, G. Roberts, A. I. Mikhail, A. E. Grzegorzewska, G. Ostromecki, A. Mostowska, A. Sowi ska, P. P. Jagodzi ski, H.-Y. Wu, H.-Y. Chen, S.-P. Hsu, M.-F. Pai, J.-Y. Yang, Y.-S. Peng, M. Hirose, T. Hasegawa, N. Kaneshima, F. Sasai, D. Komukai, K. Takahashi, F. Koiwa, K. Shishido, A. Yoshimura, G. Selim, O. Stojceva-Taneva, L. Tozija, P. Dzekova-Vidimliski, L. Trajceska, Z. Petronievic, S. Gelev, V. Amitov, A. Sikole, S. J. Moon, S. Y. Yoon, D. H. Shin, J. E. Lee, H.-J. Kim, H.-C. Park, D. Hadjiyannakos, V. Filiopoulos, G. Loukas, S. Pagonis, C. Andriopoulos, A. Drakou, D. Vlassopoulos, C. Catarino, P. Cunha, S. Ribeiro, P. Rocha-Pereira, F. Reis, M. Sameiro-Faria, V. Miranda, E. Bronze-Rocha, L. Belo, E. Costa, A. Santos-Silva, A. De Mauri, M. Brambilla, D. Chiarinotti, D. Lizio, R. Matheoud, N. Conti, M. M. Conte, A. Carriero, M. De Leo, A. V. Karpetas, P. A. Sarafidis, P. I. Georgianos, G. Koutroumpas, D. Divanis, P. Vakianis, G. Tzanis, K. Raptopoulou, A. Protogerou, D. Stamatiadis, C. Syrganis, V. Liakopoulos, G. Efstratiadis, A. N. Lasaridis, M. Tersi, D. N. Stamatiadis, P. Kuczera, M. Adamczak, A. Wiecek, S. Bove, B. Giacon, R. Corradini, E. Prati, M. Brognoli, A. Tommasi, L. Sereni, G. Palladino, H. Moriya, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, S. Hidaka, T. Ohtake, S. Kobayashi, A. Moura, J. Madureira, P. Alija, J. C. Fernandes, J. G. Oliveira, M. Lopez, M. Filgueiras, L. Amado, M. Vieira, J.-H. Seok, H. Y. Choi, S. K. Ha, H. C. Park, M. Bossola, A. Laudisio, M. Antocicco, L. Tazza, G. Colloca, M. Tosato, G. Zuccala, E. M. Ettema, J. Kuipers, H. Groen, R. T. Gansevoort, K. Stade, S. J. L. Bakker, C. A. J. M. Gaillard, R. Westerhuis, J. Bacchetta, K. Couchoud, S. Semlali, A.-L. Sellier-Leclerc, A. Bertholet-Thomas, R. Cartier, P. Cochat, B. Ranchin, J. C. Kim, K. Park, C. Van Ende, D. Wilmes, F. E. Lecouvet, L. Labriola, R. Cuvelier, G. Van Ingelgem, M. Jadoul, C. Doriana, P. David, F. Capurro, M. Brustia, C. E. Ruva, S. Giungi, E. Di Stasio, S. Lemesch, B. Leber, A. Horvath, W. Ribitsch, G. Schilcher, G. Zettel, M. Tawdrous, A. R. Rosenkranz, V. Stadlbauer-Kollner, H. Matsushima, A. Oyama, E. Bosch Benitez-Parodi, E. Baamonde Laborda, F. Batista Garcia, G. Perez Suarez, G. Anton Perez, C. Garcia Canton, A. Toledo Gonzalez, M. M. Lago Alonso, M. D. Checa Andres, G. Cobo, C. Di Gioia, R. Camacho, C. Garcia Lacalle, O. Ortega, I. Rodriguez, J. Herrero, A. Oliet, M. Ortiz, C. Mon, A. Vigil, P. Gallar, V. Pellu, P. E. Nebiolo, K. Sasaki, S. Yamguchi, A. Hesaka, E. Iwahashi, S. Sakai, T. Fujimoto, S. Minami, Y. Fujita, K. Yokoyama, E. Shutov, G. Ryabinskya, S. Lashutin, E. Gorelova, E. Volodicheva, M. A. Podesta, G. Cancarini, D. Cucchiari, A. Montanelli, S. Badalamenti, G. Graziani, E. Distasio, I. Pchelin, A. Shishkin, Y. Fedorova, C.-C. Kao, T.-S. Chu, T.-J. Tsai, K.-D. Wu, M.-S. Wu, V. Raikou, P. Kaisidis, E. Tsamparlis, P. Kanellopoulos, J. Boletis, A. Ueda, A. Hirayama, S. Owada, K. Nagai, C. Saito, and K. Yamagata
- Subjects
03 medical and health sciences ,Transplantation ,medicine.medical_specialty ,0302 clinical medicine ,Nephrology ,business.industry ,030232 urology & nephrology ,medicine ,030204 cardiovascular system & hematology ,Intensive care medicine ,Dialysis (biochemistry) ,business ,Pathophysiology - Published
- 2014
3. Extracorporeal dialysis: techniques and adequacy - A
- Author
-
D. Steckiph, G. Calabrese, A. Bertucci, A. Mazzotta, G. Vagelli, M. Gonella, D. Stamopoulos, E. Manios, N. Papachristos, E. Grapsa, G. Papageorgiou, V. Gogola, B. So, V. Dey, E. M. Spalding, C. Libetta, P. Esposito, E. Margiotta, P. Maffioli, A. Bonaventura, L. Bianchi, D. Romano, T. Rampino, G. De Rosa, A. Mauric, U. Haug, G. Enzinger, E. Kern-Derstvenscheg, A. Sluga, C. Ausserwinkler, W. Beck, A. R. Rosenkranz, V. Maheshwari, S. Haroon, Y. Loy, L. Samavedham, G. P. Rangaiah, T. Lau, N. Mpakirtzi, M. Panagiotou, D. Barbarousi, C. Matsouka, A. D. Bunani, M. Kowalczyk, P. Bartnicki, M. Banach, J. Rysz, P. Lentini, L. Zanoli, A. Granata, A. Contestabile, A. Basso, G. Berlingo, V. Pellanda, M. de Cal, V. Grazia, A. Clementi, M. Insalaco, R. Dell'Aquila, A. Karkar, M. Abdelrahman, A. R. Martins, L. Parreira, A. S. Duque, I. Rodrigues, A. B. Baffoun, M. A. Youssfi, A. Sayeh, M. Beji, R. Ben Khadra, J. Hmida, M. Akazawa, H. Horiuchi, Y. Hori, A. Yamada, H. Satou, S. Odamaki, S. Nakai, K. Satou, K. Aoki, I. Saito, Y. Kamijo, S. Ogata, Y. Ishibashi, F. Basso, M. Wojewodzka-Zelezniakowicz, D. Cruz, A. Giuliani, L. Blanca Martos, P. Piccinni, C. Ronco, J. Potier, G. Queffeulou, J. Bouet, A. Nilsson, J. Sternby, G. Grundstrom, M. Alquist, M. Ferraresi, M. C. Di Vico, F. N. Vigotti, M. Deagostini, S. Scognamiglio, V. Consiglio, R. Clari, I. Moro, E. Mongilardi, G. B. Piccoli, V. Hancock, S. Huang, K. Nilsson Ekdahl, C. Baldin, M. Petrarulo, D. Mancuso, P. Inguaggiato, G. Canepari, G. Gigliola, C. Ferrando, S. Meinero, C. Sicuso, A. Pacitti, N. Afentakis, T. Tomo, K. Matsuyama, T. Nakata, K. Ishida, T. Takeno, J.-i. Kadota, J. Minakuchi, J. Kastl, M. Merello, C. Boccato, G. Giordana, S. Mazzone, V. Moscardo, B. Reinhardt, R. Knaup, W. Kruger, D. Tovbin, S. Kim, L. Avnon, M. Zlotnik, S. Storch, K. Umimoto, Y. Shimamoto, M. Suyama, M. Miyata, E. Bosch Benitez-Parodi, E. E. Baamonde Laborda, G. Perez, J. I. Ramirez, A. Ramirez Puga, R. Guerra, C. Garcia Canton, M. M. Lago Alonso, A. Toledo, M. D. Checa Andres, F. E. Latif, Y. Mochida, K. Matsumoto, K. Morita, D. Tsutsumi, K. Ishioka, K. Maesato, M. Oka, H. Moriya, S. Hidaka, T. Ohtake, S. Kobayashi, A. Ficheux, N. Gayrard, F. Duranton, C. Guzman, I. Szwarc, J. Bismuth-Mondolfo, P. Brunet, M.-F. Servel, A. Argiles, N. Tsikliras, S. Mademtzoglou, E. Balaskas, M. Zeid, A. Mostafa, M. N. Mowafy, E. I. Abdo, O. M. Al Amin, A. Ksiazek, W. Zaluska, J. Waniewski, M. Debowska, A. Wojcik-Zaluska, M. Elias, H. Francois, E. Obada, H. K. Lorenzo, B. Charpentier, A. Durrbach, S. Beaudreuil, G. Imamovic, D. Marcelli, I. Bayh, R. Hrvacevic, S. Kapun, A. Grassmann, L. Scatizzi, J. Maslovaric, R. Daelemans, S. Mesens, E. A. Mohamed, A. Wafae, H. Kawtar, H. Mohamed Amine, K. Driss, and B. Mohammed
- Subjects
Transplantation ,medicine.medical_specialty ,Extracorporeal Dialysis ,Nephrology ,business.industry ,Medicine ,business ,Intensive care medicine - Published
- 2013
4. Epidemiology and outcome research in CKD 5D
- Author
-
L. Coentrao, C. Ribeiro, C. Santos-Araujo, R. Neto, M. Pestana, W. Kleophas, A. Karaboyas, Y. LI, J. Bommer, R. Pisoni, B. Robinson, F. Port, G. Celik, B. Burcak Annagur, M. Yilmaz, T. Demir, F. Kara, K. Trigka, P. Dousdampanis, N. Vaitsis, S. Aggelakou-Vaitsi, K. Turkmen, I. Guney, F. Turgut, L. Altintepe, H. Z. Tonbul, E. Abdel-Rahman, P. Sclauzero, G. Galli, G. Barbati, M. Carraro, G. O. Panzetta, M. Van Diepen, M. Schroijen, O. Dekkers, F. Dekker, A. Sikole, G. Severova- Andreevska, L. Trajceska, S. Gelev, V. Amitov, S. Pavleska- Kuzmanovska, H. Rayner, R. Vanholder, M. Hecking, B. Jung, M. Leung, F. Huynh, T. Chung, S. Marchuk, M. Kiaii, L. Er, R. Werb, C. Chan-Yan, M. Beaulieu, P. Malindretos, P. Makri, G. Zagkotsis, G. Koutroumbas, G. Loukas, E. Nikolaou, M. Pavlou, E. Gourgoulianni, M. Paparizou, M. Markou, E. Syrgani, C. Syrganis, J. Raimann, L. A. Usvyat, V. Bhalani, N. W. Levin, P. Kotanko, X. Huang, P. Stenvinkel, A. R. Qureshi, U. Riserus, T. Cederholm, P. Barany, O. Heimburger, B. Lindholm, J. J. Carrero, J. H. Chang, J. Y. Sung, J. Y. Jung, H. H. Lee, W. Chung, S. Kim, J. S. Han, K. Y. Na, A. Fragoso, A. Pinho, A. Malho, A. P. Silva, E. Morgado, P. Leao Neves, N. Joki, Y. Tanaka, M. Iwasaki, S. Kubo, T. Hayashi, Y. Takahashi, K. Hirahata, Y. Imamura, H. Hase, C. Castledine, J. Gilg, C. Rogers, Y. Ben-Shlomo, F. Caskey, J. S. Sandhu, G. S. Bajwa, S. Kansal, J. Sandhu, A. Jayanti, M. Nikam, L. Ebah, A. Summers, S. Mitra, J. Agar, A. Perkins, R. Simmonds, A. Tjipto, S. Amet, V. Launay-Vacher, M. Laville, A. Tricotel, C. Frances, B. Stengel, J.-Y. Gauvrit, N. Grenier, G. Reinhardt, O. Clement, N. Janus, L. Rouillon, G. Choukroun, G. Deray, A. Bernasconi, R. Waisman, A. P. Montoya, A. A. Liste, R. Hermes, G. Muguerza, R. Heguilen, E. L. Iliescu, V. Martina, M. A. Rizzo, P. Magenta, L. Lubatti, G. Rombola, M. Gallieni, C. Loirat, H. Mellerio, M. Labeguerie, B. Andriss, E. Savoye, M. Lassale, C. Jacquelinet, C. Alberti, Y. Aggarwal, J. Baharani, S. Tabrizian, S. Ossareh, M. Zebarjadi, P. Azevedo, F. Travassos, I. Frade, M. Almeida, J. Queiros, F. Silva, A. Cabrita, R. Rodrigues, C. Couchoud, J. Kitty, S. Benedicte, C. Fergus, C. Cecile, B. Sahar, V. Emmanuel, J. Christian, E. Rene, H. Barahimi, M. Mahdavi-Mazdeh, M. Nafar, M. Petruzzi, M. De Benedittis, M. Sciancalepore, L. Gargano, P. Natale, M. C. Vecchio, V. Saglimbene, F. Pellegrini, G. Gentile, P. Stroumza, L. Frantzen, M. Leal, M. Torok, A. Bednarek, J. Dulawa, E. Celia, R. Gelfman, J. Hegbrant, C. Wollheim, S. Palmer, D. W. Johnson, P. J. Ford, J. C. Craig, G. F. Strippoli, M. Ruospo, B. El Hayek, B. Hayek, E. Baamonde, E. Bosch, J. I. Ramirez, G. Perez, A. Ramirez, A. Toledo, M. M. Lago, C. Garcia-Canton, M. D. Checa, B. Canaud, B. Lantz, A. Granger-Vallee, P. Lertdumrongluk, N. Molinari, J. Ethier, M. Jadoul, B. Gillespie, C. Bond, S. Wang, T. Alfieri, P. Braunhofer, B. Newsome, M. Wang, B. Bieber, M. Guidinger, L. Zuo, X. Yu, X. Yang, J. Qian, N. Chen, J. Albert, Y. Yan, S. Ramirez, M. Beresan, A. Lapidus, M. Canteli, A. Tong, B. Manns, J. Craig, G. Strippoli, M. Mortazavi, B. Vahdatpour, S. Shahidi, A. Ghasempour, D. Taheri, S. Dolatkhah, A. Emami Naieni, M. Ghassami, M. Khan, K. Abdulnabi, P. Pai, M. Vecchio, M. A. Muqueet, M. J. Hasan, M. A. Kashem, P. K. Dutta, F. X. Liu, L. Noe, T. Quock, N. Neil, G. Inglese, M. Motamed Najjar, B. Bahmani, A. Shafiabadi, J. Helve, M. Haapio, P.-H. Groop, C. Gronhagen-Riska, P. Finne, R. Sund, M. Cai, S. Baweja, A. Clements, A. Kent, R. Reilly, N. Taylor, S. Holt, L. Mcmahon, M. Carter, F. M. Van der Sande, J. Kooman, R. Malhotra, G. Ouellet, E. L. Penne, S. Thijssen, M. Etter, A. Tashman, A. Guinsburg, A. Grassmann, C. Barth, C. Marelli, D. Marcelli, G. Von Gersdorff, I. Bayh, L. Scatizzi, M. Lam, M. Schaller, T. Toffelmire, Y. Wang, P. Sheppard, L. Neri, V. A. Andreucci, L. A. Rocca-Rey, S. V. Bertoli, D. Brancaccio, G. De Berardis, G. Lucisano, D. Johnson, A. Nicolucci, C. Bonifati, S. D. Navaneethan, V. Montinaro, M. Zsom, A. Bednarek-Skublewska, G. Graziano, J. N. Ferrari, A. Santoro, A. Zucchelli, G. Triolo, S. Maffei, S. De Cosmo, V. M. Manfreda, L. Juillard, A. Rousset, F. Butel, S. Girardot-Seguin, T. Hannedouche, M. Isnard, Y. Berland, P. Vanhille, J.-P. Ortiz, G. Janin, P. Nicoud, M. Touam, E. Bruce, B. Grace, P. Clayton, A. Cass, S. Mcdonald, Y. Furumatsu, T. Kitamura, N. Fujii, S. Ogata, H. Nakamoto, K. Iseki, Y. Tsubakihara, C.-C. Chien, J.-J. Wang, J.-C. Hwang, H.-Y. Wang, W.-C. Kan, N. Kuster, L. Patrier, A.-S. Bargnoux, M. Morena, A.-M. Dupuy, S. Badiou, J.-P. Cristol, J.-M. Desmet, V. Fernandes, F. Collart, N. Spinogatti, J.-M. Pochet, M. Dratwa, E. Goffin, J. Nortier, D. S. Zilisteanu, M. Voiculescu, E. Rusu, C. Achim, R. Bobeica, S. Balanica, T. Atasie, S. Florence, S. Anne-Marie, L. Michel, C. Cyrille, A. Strakosha, N. Pasko, S. Kodra, N. Thereska, A. Lowney, E. Lowney, R. Grant, M. Murphy, L. Casserly, T. O' Brien, W. D. Plant, J. Radic, D. Ljutic, V. Kovacic, M. Radic, K. Dodig-Curkovic, M. Sain, I. Jelicic, T. Hamano, C. Nakano, S. Yonemoto, A. Okuno, M. Katayama, Y. Isaka, M. Nordio, A. Limido, M. Postorino, M. Nichelatti, M. Khil, I. Dudar, V. Khil, I. Shifris, M. Momtaz, A. R. Soliman, M. I. El Lawindi, P. Dzekova-Vidimliski, S. Pavleska-Kuzmanovska, I. Nikolov, G. Selim, T. Shoji, R. Kakiya, N. Tatsumi-Shimomura, Y. Tsujimoto, T. Tabata, H. Shima, K. Mori, S. Fukumoto, H. Tahara, H. Koyama, M. Emoto, E. Ishimura, Y. Nishizawa, and M. Inaba
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Epidemiology ,Medicine ,business ,Intensive care medicine ,Outcome (game theory) - Published
- 2012
5. Mineral and bone disease - CKD 5D
- Author
-
M. Hecking, A. Kainz, B. Bielesz, M. Plischke, G. Beilhack, W. H. Hoerl, G. Sunder-Plassmann, C. Bieglmayer, S. Benchetrit, J. Green, J. Bernheim, E. Golan, N. Oyake, K. Suzuki, S. Itoh, K. Tanabe, A. Fujimori, S. Okada, K. Yamamoto, M. Sakai, N. Kamiura, P. Solenne, F. Guebre-Egziabher, J. Bacchetta, J. Drai, M. Richard, R. Chapurlat, D. Fouque, Z. Nowak, K. Grzegorz, K. Maria, W. Zofia, K. Zamboch, J. Zahalkova, Z. Kosatikova, P. Skypalova, J. Skarda, J. Cunha, M. Boim, V. Ferreira, M. Naves, H. Kikuchi, H. Shimada, Y. Takimoto, R. Karasawa, M. Shimotori, K. Ikarashi, N. Saito, S. Miyazaki, S. Sakai, M. Suzuki, H. Ogata, A. Takeshima, M. Yamamoto, K. Asakura, T. Kato, K. Shishido, F. Koiwa, M. Mizobuchi, E. Kinugasa, T. Akizawa, F. Londrino, V. Corbani, M. Ardini, V. Falqui, T. Zattera, G. Rombola', Y. Takeshige, K. Matsuzaka, P. Ciceri, E. Volpi, I. Brenna, F. Elli, E. Borghi, D. Brancaccio, M. Cozzolino, K. Farrand, J. B. Copley, J. Heise, M. Fridman, M. Keith, A. Silverberg, R. Wilson, L. Poole, G. Jean, E. Bresson, C. Chazot, F. Maduell, M. Arias, A. Sentis, N. Rodriguez, S. Jimenez, B. Alemany, N. Perez, M. Vera, N. Fontsere, M. Carrera, A. Cases, M. Sonikian, T. Miha, I. Skarakis, I. Karatzas, A. Karaitianou, V. Tomanoski, D. Petkovic, I. Curic, R. Hrvacevic, N. Kaperonis, C. Kourvelou, A. Sgantzos, D. Nastou, G. Ntatsis, S. Ziakka, F. Karakasis, V. Nikolopoulos, D. Zoubaniotou, A. Koutsovasili, A. Zagorianakos, V. Kolovos, N. Papagalanis, V. Forni, M. Pruijm, E. Tousset, C. Zweiacker, I. Menetrey, L. Berwert, R. Bullani, A. Cherpillod, L. Gabutti, T. Gauthier, G. Halabi, C. Mathieu, P. Meier, O. Phan, S. Pianca, C. Schoenholzer, D. Teta, B. Von Albertini, B. Vrijens, M. Burnier, N. Kurita, M. Fukagawa, Y. Onishi, T. Yamaguchi, T. Hasegawa, S. Fukuma, K. Kurokawa, S. Fukuhara, P. Urena, I. Bridges, C. Christiano, S. Cournoyer, K. Cooper, M. Farouk, N. Kopyt, M. Rodriguez, D. Zehnder, A. Covic, Y. Tominaga, T. Hiramitsu, T. Yamamoto, K. Nanmoku, Y. Matsuda, T. Tsuzuki, C.-L. Lang, K.-C. Lu, M.-H. Wang, S.-Y. Liu, J.-W. Huang, C.-K. Chiang, K.-Y. Hung, C. Bantis, N.-M. Kouri, E. Tsandekidou, S. Frangidis, A. Tsiandoulas, E. Liakou, G. Bamichas, M. Stangou, A. Papagianni, G. Efstratiadis, T. Natse, D. Memmos, P. Messa, G. Cannella, S. Mazzaferro, X. Yu, B. Bieber, M. Guidinger, X. Yang, F. Tentori, R. Pisoni, J. Qian, N. Chen, Y. Yan, M. Wang, L. Zuo, H. Wang, J. Albert, S. Ramirez, F. Caccetta, M. Caroppo, F. Musio, A. Mudoni, A. Accogli, M. D. Zacheo, V. Nuzzo, G. Selim, O. Stojceva-Taneva, L. Tozija, S. Gelev, V. Pusevski, P. Dzekova-Vidimliski, I. Rambabova-Busletic, A. Sikole, P. Esposito, R. Coppo, F. Malberti, A. Dal Canton, K. Moriwaki, H. Komaba, T. Kakuta, V. Cernaro, R. Lupica, V. Donato, A. Lacquaniti, M. R. Fazio, S. Lucisano, M. Buemi, S. Okuno, E. Ishimura, N. Tsuboniwa, K. Norimine, K. Yamakawa, T. Yamakawa, S. Shoji, K. Mori, Y. Nishizawa, M. Inaba, M. Dahaba, S. Seck, M. Cisse, Y. Jotoku, Y. Sato, N. Dimkovic, E. Asicioglu, A. Kahveci, H. Arikan, M. Koc, S. Tuglular, C. Ozener, R. Kido, T. Yamaguch, A. Krasniak, M. Drozdz, G. Chmiel, P. Podolec, M. Pasowicz, M. Kowalczyk-Michalek, W. Sulowicz, G. Perez-Suarez, E. Baamonde, E. Bosch, J. I. Ramirez, B. El Hayek, M. D. M. Lago, C. Garcia, M. D. Checa, R. Hiramatsu, Y. Ubara, K. Salas, E. S. Vicent, J. C. Gonzalez Oliva, M. Fulquet, V. Duarte, M. Pou, A. Saurina, J. Macias, M. Ramirez de Arellano, P. Matias, C. Jorge, M. Mendes, T. Amaral, C. Ferreira, I. Aires, C. Gil, A. Ferreira, C. Arcal, J. M. Campistol, S. Seferi, M. Rroji, E. Likaj, E. Petrela, M. Barbullushi, N. Zeneli, S. Mumajesi, N. Thereska, C. Vulpio, M. Bossola, E. Stigliano, G. Fadda, A. P. S. Gueiros, J. O. Borba Junior, A. B. d. M. D. S. Lordsllen, J. E. d. B. Gueiros, N. Itami, K. Tuneyama, S. Uemura, H. Hamada, J. Takada, K. Takahashi, K. Adamidis, T. Apostolou, C. Pleros, T. Oikonomaki, E. Kyratzi, D. Exarchos, G. Metaxatos, S. Dracopoulos, N. Nikolopoulou, P. Delanaye, B. Dubois, J.-M. Krzesinski, E. Cavalier, V. De la Fuente, M. T. Gil, P. Gutierrez, P. Delgado, J. Ribero, L. Arenas, S. Sezer, E. Tutal, Z. Bal, M. Erkmen Uyar, F. N. Ozdemir Acar, R. Azevedo de Oliveira, F. Carvalho Barreto, L. Dos Reis, J. Cunha Ferreira, Z. Maria Leme Britto, R. Maria Moyses, V. Jorgetti, R. Ozelsancak, B. Gurlek Demirci, D. Torun, L. Veljancic, M. Radojevic, Z. Paunic, N. Vavic, K. Obrencevic, Z. Kovacevic, and J. Pejovic
- Subjects
Transplantation ,Nephrology - Published
- 2012
6. Cardiovascular complications in CKD 5D
- Author
-
M. Fusaro, M. Noale, G. Tripepi, A. D'angelo, D. Miozzo, M. Gallieni, P.-V. Study Group, M. Tsamelesvili, C. Dimitriadis, A. Papagianni, C. Raidis, G. Efstratiadis, D. Memmos, R. Mutluay, C. Konca Degertekin, U. Derici, S. M. Deger, F. Akkiyal, S. Gultekin, S. Gonen, G. Tacoy, T. Arinsoy, S. Sindel, C. Sanchez-Perales, E. Vazquez, E. Merino, P. Perez Del Barrio, F. J. Borrego, M. J. Borrego, A. Liebana, M. Krzanowski, K. Janda, P. Dumnicka, A. Krasniak, W. Sulowicz, Y.-O. Kim, S.-A. Yoon, Y.-S. Yun, H.-C. Song, B.-S. Kim, M. A. Cheong, A. Pasch, S. Farese, J. Floege, W. Jahnen-Dechent, T. Ohtake, R. Furuya, M. Iwagami, D. Tsutsumi, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, H. Moriya, S. Hidaka, S. Kobayashi, A. Guedes, A. Malho Guedes, A. Pinho, A. Fragoso, A. Cruz, P. Mendes, E. Morgado, I. Bexiga, A. P. Silva, P. Neves, N. Oyake, K. Suzuki, S. Itoh, S. Yano, K. Turkmen, H. Kayikcioglu, O. Ozbek, M. Saglam, A. Toker, H. Z. Tonbul, S. Gelev, L. Trajceska, E. Srbinovska, S. Pavleska, V. Amitov, G. Selim, P. Dzekova, A. Sikole, H. Bouarich, S. Lopez, C. Alvarez, I. Arribas, P. DE Sequera, D. Rodriguez, S. Tanaka, T. Kanemitsu, M. Sugahara, M. Kobayashi, L. Uchida, Y. Ishimoto, N. Kotera, S. Tanimoto, K. Tanabe, K. Hara, T. Sugimoto, N. Mise, B. Goldstein, M. Turakhia, C. Arce, W. Winkelmayer, B. E.-D. Zayed, K. Said, M. Nishimura, Y. Okamoto, T. Tokoro, M. Nishida, T. Hashimoto, N. Iwamoto, H. Takahashi, T. Ono, N. Sato, J. Raimann, L. A. Usvyat, J. Sands, N. W. Levin, P. Kotanko, M. Iwasaki, N. Joki, Y. Tanaka, N. Ikeda, T. Hayashi, S. Kubo, T.-A. Imamura, Y. Takahashi, K. Hirahata, Y. Imamura, H. Hase, K. Claes, B. Meijers, B. Bammens, D. Kuypers, M. Naesens, Y. Vanrenterghem, P. Evenepoel, G. Boscutti, L. Calabresi, M. Bosco, S. Simonelli, E. Boer, C. Vitali, M. Martone, P. L. Mattei, G. Franceschini, E. Baligh, E. El-Shafey, A. Ezaat, A. Zawada, K. Rogacev, B. Hummel, O. Grun, A. Friedrich, B. Rotter, P. Winter, J. Geisel, D. Fliser, G. H. Heine, J.-I. Makino, K.-S. Makino, T. Ito, S. Genovesi, A. Santoro, P. Fabbrini, E. Rossi, D. Pogliani, A. Stella, G. Bonforte, G. Remuzzi, S. Bertoli, C. Pozzi, S. Pasquali, L. Cagnoli, F. Conte, I. Buzadzic, J. Tosic, N. Dimkovic, Z. Djuric, J. Popovic, I. Pejin Grubisa, N. Barjaktarevic, A. DI Napoli, D. DI Lallo, M. F. Salvatori, F. Franco, S. Chicca, G. Guasticchi, M. Onofriescu, S. Hogas, V. Luminita, A. Mugurel, V. Gabriel, F. Laura, M. Irina, C. Adrian, E. Bosch, E. Baamonde, C. Culebras, G. Perez, B. El Hayek, J. I. Ramirez, A. Ramirez, C. Garcia, M. Lago, A. Toledo, M. D. Checa, T. Taira, T. Hirano, K. Nohtomi, T. Hyodo, T. Chiba, A. Saito, Y. K. Kim, E. J. Choi, C. W. Yang, Y.-S. Kim, P. S. Lim, W. Ming Ying, J. Ya-Chung, I. Zaripova, I. Kayukov, A. Essaian, A. Nimgirova, H. Young, M. Dungey, E. L. Watson, R. Baines, J. O. Burton, A. C. Smith, K. Yamazaki, M. Bossola, L. Colacicco, D. Scribano, C. Vulpio, L. Tazza, T. Okada, N. Okada, I. Michibata, T. Yura, N. Montero, M. Soler, M. Pascual, C. Barrios, E. Marquez, E. Rodriguez, M. A. Orfila, H. Cao, E. Arcos, J. Comas, J. Pascual, M. Ferrario, F. Garzotto, T. Sironi, S. Monacizzo, F. Basso, D. N. Cruz, U. Moissl, C. Tetta, M. G. Signorini, S. Cerutti, C. Ronco, I. Mostovaya, M. Grooteman, M. Van den Dorpel, L. Penne, N. Van der Weerd, A. Mazairac, C. Den Hoedt, R. Levesque, M. Nube, P. Ter Wee, M. Bots, P. Blankestijn, J. Liu, K. L. MA, X. Zhang, B. C. Liu, I.-D. Vladu, R. Mustafa, D. Cana-Ruiu, C. Vaduva, C. Grauntanu, E. Mota, R. Singh, N. Abbasian, C. Stover, N. Brunskill, J. Burton, K. Herbert, A. Bevington, M. Wu, R.-N. Tang, M. Gao, H. Liu, L. Chen, L.-L. LV, B.-C. Liu, M. Nikodimopoulou, S. Liakos, S. Kapoulas, C. Karvounis, D. Fedak, M. Kuzniewski, D. Paulina, B. Kusnierz-Cabala, M. Kapusta, B. Solnica, A. Junque, E. S. Vicent, L. Moreno, M. Fulquet, V. Duarte, A. Saurina, M. Pou, J. Macias, M. Lavado, M. Ramirez de Arellano, M. Ryuzaki, H. Nakamoto, S. Kinoshita, E. Kobayashi, C. Takimoto, T. Shishido, G. Enia, C. Torino, R. Tripepi, V. Panuccio, M. Postorino, A. Clementi, M. Garozzo, G. Bonanno, R. Boito, G. Natale, T. Cicchetti, A. Chippari, D. Logozzo, G. Alati, S. Cassani, A. Sellaro, C. Zoccali, B. Quiroga, E. Verde, S. Abad, A. Vega, M. Goicoechea, J. Reque, J. M. Lopez-Gomez, J. Luno, C. Cabre Menendez, V. Moles, J. P. Vives, D. Villa, J. Vinas, T. Compte, M. Arruche, C. Diaz, J. Soler, J. Aguilera, A. Martinez Vea, A. De Mauri, P. David, M. M. Conte, D. Chiarinotti, C. E. Ruva, M. De Leo, A.-S. Bargnoux, M. Morena, I. Jaussent, L. Chalabi, P. Bories, J.-J. Dion, P. Henri, M. Delage, A.-M. Dupuy, S. Badiou, B. Canaud, J.-P. Cristol, E. Sironi, F. Pieruzzi, E. Galbiati, M. R. Vigano, S. Anpalakhan, S. Rocha, N. Chitalia, R. Sharma, J. C. Kaski, J. Chambers, D. Goldsmith, D. Banerjee, V. Cernaro, A. Lacquaniti, R. Lupica, S. Lucisano, M. R. Fazio, V. Donato, M. Buemi, I. Segalen, U. Vinsonneau, T. Tanquerel, G. Quiniou, Y. Le Meur, E. Seibert, M. Girndt, K. Zohles, C. Ulrich, A. Kluttig, S. Nuding, C. Swenne, J. Kors, K. Werdan, R. Fiedler, N. C. Van der Weerd, M. P. Grooteman, M. A. Van den Dorpel, M. J. Nube, J. Wetzels, D. W. Swinkels, P. M. Ter Wee, A. Khandekar, J. Khandge, J. E. Lee, S. J. Moon, K. H. Choi, H. Y. Lee, B. S. Kim, E. Tuaillon, A. Rodriguez, L. Chenine, J.-P. Vendrell, Y.-M. Sue, C.-H. Tang, Y.-C. Chen, P. Segura, M. J. Garcia Cortes, J. M. Gil, M. M. Biechy, D. Poulikakos, A. Shah, M. Persson, P. Dattolo, M. Amidone, S. Michelassi, L. Moriconi, G. Betti, P. Conti, A. Rosati, A. Mannarino, V. Panichi, F. Pizzarelli, K. Klejna, B. Naumnik, E. Koc-Zorawska, M. Mysliwiec, S. Dimitrie, H. Simona, O. Mihaela, O. Gabriela, S. Radu, P. Octavian, H. Akdam, H. Akar, Y. Yenicerioglu, O. Kucuk, I. Kurt Omurlu, S. Thambiah, R. Roplekar, P. Manghat, I. Fogelman, W. Fraser, G. Hampson, E. Likaj, G. Caco, S. Seferi, M. Rroji, M. Barbullushi, N. Thereska, A. Serban, V. Carmen, S. Cristian, L. Silvia, and A. Covic
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,medicine ,Intensive care medicine ,business - Published
- 2012
7. Adequacy of Dialysis in Automated Peritoneal Dialysis: A Clinical Experience
- Author
-
A Morales Umpierrez, M Navarro Zurita, C Plaza Toledano, N Vega Díaz, L Palop Cubillo, E Baamonde Laborda, P. Pérez Borges, and AM Fernández Rodríguez
- Subjects
medicine.medical_specialty ,Creatinine ,business.industry ,medicine.medical_treatment ,Continuous ambulatory peritoneal dialysis ,030232 urology & nephrology ,Urology ,General Medicine ,medicine.disease ,Uremia ,Surgery ,Peritoneal dialysis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Nephrology ,Ambulatory ,medicine ,Equilibrium dialysis ,030212 general & internal medicine ,business ,Dialysis ,Kidney disease - Abstract
Objectives To compare the peritoneal clearances of urea and creatinine in continuous ambulatory peritoneal dialysis (CAPD) with three types of automated peritoneal dialysis (APD): continuous cycling peritoneal dialysis (CCPD), 50% tidal peritoneal dialysis (TPD), and 25% TPD and to assess the usefulness of the peritoneal equilibration test (PET) in predicting peritoneal clearances in overnight APD. Patients Eleven uremic patients (mean age 44.5 ± 15.45 years with a mean time on dialysis of 42.63 ± 25.62 months) were included in the study. Measurements PET for urea and creatinine following Twardowski's method. Peritoneal clearances for urea and creatinine CAPD: samples of blood and dialysate within 24 hours. APD: blood mean levels of urea and creatinine before and after nighttime dialysis. Dialysate: urea and creatinine in nocturnal and daytime dialysate. Results Peritoneal clearance of creatinine was 38.14 ± 9.99 L/week/1.73 m2 in CAPD, 44.28 ± 12.4 L/week/1.73 m2 in CCPD, 50.07 ± 17.86 L/week/1.73 m2 in 50% TPD (p < 0.05) and 40.18 ± 6.65 L/week/1.73 m2 in 25% TPD. Peritoneal clearance of urea improved significantly in the three modalities of APD: 51.91 ± 12.58 L/week/1.73 m2 in CAPD; 66.7 ± 9.9 L/week/1. 73 m2 in CCPD (p < 0.05); 76.3 ± 14.5 L/week/1. 73 m2 in 50% TPD (p < 0.001) and 64.3 ± 11.4 L/week/1.73 m2 in 25% TPD (p < 0.05). The dialysatel plasma (DIP) ratio of creatinine at 30,60, 120,180, and 240 minutes showed significant correlation with nighttime APD clearance. Nevertheless, only the DIP ratio of urea at 30, 60, and 120 minutes correlated with overnight APD clearance. Conclusions A remarkable improvement was observed with APD regarding the clearance of urea mainly when 50% tidal peritoneal dialysis was used, whereas it was less noticeable in the clearance of creatinine. The PET is a helpful tool in predicting overnight peritoneal clearances of creatinine but it is less useful in predicting urea clearance.
- Published
- 1997
8. Surveillance for infections and other adverse events in dialysis patients in southern Gran Canaria
- Author
-
A, Quori, E, Baamonde-Laborda, C, García-Cantón, M M, Lago-Alonso, A, Toledo-González, E, Monzón-Jiménez, D, Jiménez-Díaz, M, Checa-de-Andrés, and J, Molina-Cabrillana
- Subjects
Cross Infection ,Risk Management ,Incidence ,Bacteremia ,Thrombosis ,Anti-Bacterial Agents ,Arteriovenous Shunt, Surgical ,Catheters, Indwelling ,Renal Dialysis ,Spain ,Catheter-Related Infections ,Drug Resistance, Multiple, Bacterial ,Population Surveillance ,Atlantic Islands ,Humans ,Kidney Failure, Chronic ,Prospective Studies ,Gram-Negative Bacterial Infections ,Peritoneal Dialysis ,Gram-Positive Bacterial Infections - Abstract
Bacterial infections pose a major challenge to risk management activities in the area of chronic haemodialysis, as vascular access-related infections are the main cause of mortality among these patients.Prospective surveillance study lasting 7 months (March-September, 2008) at two haemodialysis units in a district health area Gran Canaria, Spain. We used the methodology proposed by CDC´s Dialysis Surveillance Network.1545 patients/month were recorded, 60.5% with an arteriovenous fistula (AVF), 35.5% with a permanent catheter (PC), 3.0% with grafts and 1.0% with temporary catheters. The rate of adverse events was 8.6 cases per 100 patients/month, 9.1 for AVF patients, and 2.9 for PC. Nevertheless, the other types of infections (respiratory, urinary tract, skin and chronic ulcers) showed similar rates. Microbiological cultures were taken in 82.2%, but this rate increased to 91.0% when a vascular access-related infection was suspected. Empirical treatment was adjusted to antibiogram results in 90.0% of occasions. A low incidence of multi-resistant microbes was observed. Gram-positive and gram-negative bacteria appeared in similar proportions.Vascular access is the main risk factor for infectious events. Epidemiological surveillance has allowed us to detect areas of improvement in different settings, acting as a key element in risk management and patient safety.
- Published
- 2011
9. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index
- Author
-
A Losada, A Fernández, L Hortal, M Lorenzo, L Palop, R. Gallego, E. Baamonde, C Plaza, and N Vega
- Subjects
Male ,Transplantation ,medicine.medical_specialty ,Time Factors ,business.industry ,Urology ,Prognosis ,Kidney Transplantation ,Body Mass Index ,Surgery ,Proteinuria ,Renal transplant ,Creatinine ,Cyclosporine ,Humans ,Medicine ,Female ,Obesity ,Drug Monitoring ,business ,Body mass index ,Immunosuppressive Agents - Published
- 2001
10. Increase of plasma aluminium levells pot iron I.V. infusion
- Author
-
J. Botella, C.Sanz Moreno, E. Baamonde, and J. Harnandez
- Subjects
Histology ,chemistry ,Physiology ,Aluminium ,Endocrinology, Diabetes and Metabolism ,I v infusion ,chemistry.chemical_element ,Plasma ,Nuclear chemistry - Published
- 1993
11. [Role of expanded hemodialysis in COVID-19: a case report].
- Author
-
Valga F, Vega-Díaz N, Monzón T, González-Cabrera F, Santana A, Baamonde E, Gallego R, Quevedo-Reina JC, and Rodríguez-Pérez JC
- Subjects
- Aged, COVID-19, Coronavirus Infections therapy, Humans, Male, Oliguria etiology, Pandemics, Pneumonia, Viral therapy, SARS-CoV-2, Betacoronavirus, Coronavirus Infections complications, Hemodiafiltration methods, Oliguria therapy, Pneumonia, Viral complications
- Published
- 2020
- Full Text
- View/download PDF
12. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
- Author
-
Oliva-Damaso E, Oliva-Damaso N, Rodriguez-Esparragon F, Payan J, Baamonde-Laborda E, Gonzalez-Cabrera F, Santana-Estupiñan R, and Rodriguez-Perez JC
- Subjects
- Aging metabolism, Animals, Arginine metabolism, Cardiovascular Diseases diagnosis, Cardiovascular Diseases etiology, Cardiovascular Diseases metabolism, Endothelium, Vascular metabolism, Endothelium, Vascular physiopathology, Humans, Metabolic Networks and Pathways drug effects, Molecular Targeted Therapy, Prognosis, Renal Dialysis, Renal Insufficiency, Chronic mortality, Renal Insufficiency, Chronic therapy, Arginine analogs & derivatives, Renal Insufficiency, Chronic etiology, Renal Insufficiency, Chronic metabolism
- Abstract
Asymmetric dimethylarginine (ADMA) and its enantiomer, Symmetric dimethylarginine (SDMA), are naturally occurring amino acids that were first isolated and characterized in human urine in 1970. ADMA is the most potent endogenous inhibitor of nitric oxide synthase (NOS), with higher levels in patients with end-stage renal disease (ESRD). ADMA has shown to be a significant predictor of cardiovascular outcome and mortality among dialysis patients. On the other hand, although initially SDMA was thought to be an innocuous molecule, we now know that it is an outstanding marker of renal function both in human and in animal models, with ESRD patients on dialysis showing the highest SDMA levels. Today, we know that ADMA and SDMA are not only uremic toxins but also independent risk markers for mortality and cardiovascular disease (CVD). In this review, we summarize the role of both ADMA and SDMA in chronic kidney disease along with other cardiovascular risk factors.
- Published
- 2019
- Full Text
- View/download PDF
13. Fluctuation of pre-hemodialysis serum sodium .
- Author
-
Oliva-Damaso N, Baamonde-Laborda E, Oliva-Damaso E, Payan J, Marañes A, Vega-Diaz N, and Rodriguez-Perez JC
- Subjects
- Aged, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Kidney Failure, Chronic therapy, Male, Middle Aged, Proportional Hazards Models, Renal Dialysis, Retrospective Studies, Survival Rate, Hyponatremia blood, Hyponatremia complications, Kidney Failure, Chronic blood, Kidney Failure, Chronic complications, Sodium blood
- Abstract
Introduction: Low pre-hemodialysis (pre-HD) serum sodium or hyponatremia is associated with higher mortality. Pre-HD serum sodium can be more stable over time with low fluctuation compared to other serum parameters., Materials and Methods: We examined variation of pre-HD serum sodium in 24 months and after this point examined all-cause mortality in a cohort of 261 patients followed-up for 48.8 (standard deviation (SD) = 19.1) months. 6,221 determinations of pre-HD serum sodium were made and corrected for glucose concentrations. Serum sodium was measured pre-HD monthly, and the variability was calculated using the coefficient of variation (CV)., Results: The mean age was of 60 ± 14.1 years, 60.9% were men, 48% had diabetes mellitus, and diabetic nephropathy was the most frequent cause of end-stage renal disease. Median CV of sodium in 24 months was 1.7% with a mean of 1.78% (95% CI 1.73 - 1.83). Patients with CV > 1.7% had a higher mortality (53 patients a 36.8%) compared to CV < 1.7% (22 patients a 18.8%) (p = 0.002). In Kaplan-Meier analysis, patients with CV > 1.7% had significantly worse overall survival (log rank = 6.395, p = 0.011). We also stratified the sample in serum sodium tertiles (< 138 mEq/L; 138 - 140 mEq/L; > 140 mEq/L) and made a Kaplan-Meier analysis which showed persistent worse survival outcomes in patients with CV > 1.7% (log rank Mantel-Cox 7.64; p = 0.006). Cox regression multivariate model showed that CV of sodium was significantly associated with overall mortality after adjusting for confounder variables (hazard ratio 2.16, 95% CI 1.37 - 3.41; p = 0.001)., Conclusion: Variation of pre-HD serum sodium in 2 years is less than a 2%. With the limitations of our study, a higher variability of pre-HD serum sodium in 2 years of treatment (CV > 1.7%) is associated with increased mortality. .
- Published
- 2018
- Full Text
- View/download PDF
14. Impact of a phone app on nephrology referral.
- Author
-
Oliva-Damaso N, Oliva-Damaso E, Rivas-Ruiz F, Lopez F, Castilla MDM, Baamonde-Laborda E, Rodriguez-Perez JC, and Payan J
- Abstract
Background: Various factors can lead to inadequate nephrology referral decisions being taken by clinicians, but a major cause is unawareness of guidelines, recommendations and indications, or of appropriate timing. Today, tools such as smartphone applications (Apps) can make this knowledge more accessible to non-nephrologist clinicians. Our study aim is to determine the effectiveness of a purpose-built app in this respect., Methods: In a retrospective study, nephrology referrals were compared before and after the introduction of the app in clinical practice. The initial study population consisted of first visits by patients referred to our department in 2015, before the introduction of the app. In 2016, the smartphone app NefroConsultor began to be implemented in our hospital. We compared the initial study population with the results obtained for patients referred in 2017, when the app was in use, taking into account clinical features considered, such as urinalysis, proteinuria or kidney ultrasound, to determine whether these patients met currently recommended criteria for referral., Results: The total study population consisted of 628 patients, of whom 333 were examined before the introduction of the app (in 2015) and 295 when it was in use (in 2017). Among the first group, 132 (39.6%) met established KDIGO criteria for nephrology referral and were considered to be correctly referred. Among the second group, 200 (67.8%) met the criteria and were considered to be properly referred (P = 0.001). The increase in the rate of intervention success (before-after app) was 28.8% with a binomial effect size display (Cohen's d effect size) of 0.751. Before the introduction of the app, data for albuminuria were included in 62.5% of nephrology referrals; in 2017, the corresponding value was 87.5% (P = 0.001). In the same line, referrals including urinalysis rose from 68.5% to 85.8% (P = 0.001). Multivariate regression analysis, using referrals meeting KDIGO criteria as the dependent variable and adjusting for age, sex and referring department, showed that the 2017 group (after the introduction of NefroConsultor) was associated with an odds ratio of 3.57 (95% confidence interval 2.52-5.05) for correct referrals, compared with the 2015 group (P = 0.001). References to proteinuria as the reason for nephrology referral also increased from 23.7% to 34.2% (P = 0.004)., Conclusions: Use of the app is associated with more frequent studies of albuminuria at the time of referral and a greater likelihood of proteinuria being cited as the reason for referral. The smartphone app considered can improve the accessibility of information concerning nephrology referrals and related studies.
- Published
- 2018
- Full Text
- View/download PDF
15. Surveillance for infections and other adverse events in dialysis patients in southern Gran Canaria.
- Author
-
Quori A, Baamonde-Laborda E, García-Cantón C, Lago-Alonso MM, Toledo-González A, Monzón-Jiménez E, Jiménez-Díaz D, Checa-de-Andrés M, and Molina-Cabrillana J
- Subjects
- Anti-Bacterial Agents therapeutic use, Arteriovenous Shunt, Surgical adverse effects, Atlantic Islands epidemiology, Bacteremia drug therapy, Bacteremia epidemiology, Bacteremia etiology, Bacteremia microbiology, Catheter-Related Infections drug therapy, Catheter-Related Infections etiology, Catheter-Related Infections microbiology, Cross Infection drug therapy, Cross Infection etiology, Cross Infection microbiology, Drug Resistance, Multiple, Bacterial, Gram-Negative Bacterial Infections drug therapy, Gram-Negative Bacterial Infections epidemiology, Gram-Negative Bacterial Infections etiology, Gram-Negative Bacterial Infections microbiology, Gram-Positive Bacterial Infections drug therapy, Gram-Positive Bacterial Infections epidemiology, Gram-Positive Bacterial Infections etiology, Gram-Positive Bacterial Infections microbiology, Humans, Incidence, Kidney Failure, Chronic complications, Prospective Studies, Risk Management, Spain epidemiology, Thrombosis etiology, Catheter-Related Infections epidemiology, Catheters, Indwelling adverse effects, Cross Infection epidemiology, Kidney Failure, Chronic therapy, Peritoneal Dialysis, Population Surveillance, Renal Dialysis, Thrombosis epidemiology
- Abstract
Background: Bacterial infections pose a major challenge to risk management activities in the area of chronic haemodialysis, as vascular access-related infections are the main cause of mortality among these patients., Methods: Prospective surveillance study lasting 7 months (March-September, 2008) at two haemodialysis units in a district health area Gran Canaria, Spain. We used the methodology proposed by CDC´s Dialysis Surveillance Network., Results: 1545 patients/month were recorded, 60.5% with an arteriovenous fistula (AVF), 35.5% with a permanent catheter (PC), 3.0% with grafts and 1.0% with temporary catheters. The rate of adverse events was 8.6 cases per 100 patients/month, 9.1 for AVF patients, and 2.9 for PC. Nevertheless, the other types of infections (respiratory, urinary tract, skin and chronic ulcers) showed similar rates. Microbiological cultures were taken in 82.2%, but this rate increased to 91.0% when a vascular access-related infection was suspected. Empirical treatment was adjusted to antibiogram results in 90.0% of occasions. A low incidence of multi-resistant microbes was observed. Gram-positive and gram-negative bacteria appeared in similar proportions., Conclusions: Vascular access is the main risk factor for infectious events. Epidemiological surveillance has allowed us to detect areas of improvement in different settings, acting as a key element in risk management and patient safety.
- Published
- 2011
- Full Text
- View/download PDF
16. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
- Author
-
Hortal L, Fernández A, Losada A, Lorenzo M, Baamonde E, Plaza C, Gallego R, Vega N, and Palop L
- Subjects
- Creatinine blood, Cyclosporine therapeutic use, Drug Monitoring methods, Female, Humans, Immunosuppressive Agents therapeutic use, Kidney Transplantation immunology, Male, Obesity blood, Obesity physiopathology, Prognosis, Proteinuria, Time Factors, Body Mass Index, Cyclosporine blood, Immunosuppressive Agents blood, Kidney Transplantation physiology
- Published
- 2001
- Full Text
- View/download PDF
17. Adequacy of dialysis in automated peritoneal dialysis: a clinical experience.
- Author
-
Fernández Rodríguez AM, Vega Díaz N, Palop Cubillo L, Baamonde Laborda E, Morales Umpierrez A, Pérez Borges P, Navarro Zurita M, and Plaza Toledano C
- Subjects
- Adult, Creatinine metabolism, Female, Humans, Kidney physiopathology, Kidney Failure, Chronic physiopathology, Kidney Failure, Chronic therapy, Male, Middle Aged, Peritoneal Dialysis, Continuous Ambulatory, Peritoneum metabolism, Urea metabolism, Peritoneal Dialysis methods
- Abstract
Objectives: To compare the peritoneal clearances of urea and creatinine in continuous ambulatory peritoneal dialysis (CAPD) with three types of automated peritoneal dialysis (APD): continuous cycling peritoneal dialysis (CCPD), 50% tidal peritoneal dialysis (TPD), and 25% TPD and to assess the usefulness of the peritoneal equilibration test (PET) in predicting peritoneal clearances in overnight APD., Patients: Eleven uremic patients (mean age 44.5 +/- 15.45 years with a mean time on dialysis of 42.63 +/- 25.62 months) were included in the study., Measurements: PET for urea and creatinine following Twardowski's method. Peritoneal clearances for urea and creatinine CAPD: samples of blood and dialysate within 24 hours. APD: blood mean levels of urea and creatinine before and after nighttime dialysis. Dialysate: urea and creatinine in nocturnal and daytime dialysate., Results: Peritoneal clearance of creatinine was 38.14 +/- 9.99 L/week/1.73 m2 in CAPD, 44.28 +/- 12.4 L/week/1.73 m2 in CCPD, 50.07 +/- 17.86 L/week/1.73 m2 in 50% TPD (p < 0.05) and 40.18 +/- 6.65 L/week/1.73 m2 in 25% TPD. Peritoneal clearance of urea improved significantly in the three modalities of APD: 51.91 +/- 12.58 L/week/1.73 m2 in CAPD; 66.7 +/- 9.9 L/week/1.73 m2 in CCPD (p < 0.05); 76.3 +/- 14.5 L/week/1.73 m2 in 50% TPD (p < 0.001) and 64.4 +/- 11.4 L/week/1.73 m2 in 25% TPD (p < 0.05). The dialysate/ plasma (D/P) ratio of creatinine at 30, 60, 120, 180, and 240 minutes showed significant correlation with nighttime APD clearance. Nevertheless, only the D/P ratio of urea at 30, 60, and 120 minutes correlated with overnight APD clearance., Conclusions: A remarkable improvement was observed with APD regarding the clearance of urea mainly when 50% tidal peritoneal dialysis was used, whereas it was less noticeable in the clearance of creatinine. The PET is a helpful tool in predicting overnight peritoneal clearances of creatinine but it is less useful in predicting urea clearance.
- Published
- 1997
18. Nutritional status of CAPD patients at three years.
- Author
-
Palop L, Vega N, Rodriguez T, Fernandez A, Rodriguez JC, Plaza C, Hortal L, Perdomo M, Baamonde E, Perez P, and Martinez JA
- Subjects
- Adult, Aged, Anthropometry, Diabetic Nephropathies immunology, Diabetic Nephropathies therapy, Female, Follow-Up Studies, Humans, Kidney Failure, Chronic immunology, Lymphocyte Count, Lymphocyte Subsets immunology, Male, Middle Aged, Protein-Energy Malnutrition immunology, Serum Albumin metabolism, Kidney Failure, Chronic therapy, Nutrition Assessment, Peritoneal Dialysis, Continuous Ambulatory, Protein-Energy Malnutrition etiology
- Abstract
A nutritional assessment was carried out in 63 patients starting treatment from April 1990 up to December 1993. Anthropometric measurements were performed showing a prevalence of protein-calorie malnutrition (PCM) of 21% in a total of 142 clinical surveys carried out in the above-mentioned sample. A steady state of albumin levels in plasma was verified during a three-year follow-up period at a lower level than that of the control group. The patients' lymphocytic profile throughout the study was characterized by lymphopenia and decreased B and T8 lymphocytes. During the first two years of continuous ambulatory peritoneal dialysis (CAPD), a high percentage of patients met the "adequacy" dialysis criteria as residual renal function plays an important role as regards treatment.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.